AI Revolutionizes Clinical Trials: Veeda Lifesciences Invests in US Healthcare Tech

Ahmedabad, July 8, 2025: Veeda Lifesciences, a prominent global Contract Research Organisation (CRO), has announced a strategic investment in Mango Sciences, a Boston-based leader in AI-powered healthcare solutions.

This move signifies Veeda’s commitment to leveraging cutting-edge technology to enhance its clinical trial services. The investment will integrate Mango Sciences’ Querent platform into Veeda’s operations.

The Querent platform uses AI to automate patient identification, promising faster, more efficient, and globally representative patient recruitment for clinical trials. This will significantly improve the speed and quality of trials.

This technological advancement is expected to benefit Veeda’s expanding global network, particularly in Europe, where it aims to broaden its reach.

The collaboration highlights the growing importance of AI in the healthcare sector, promising accelerated drug development and improved access to clinical trials for a more diverse patient population. This development holds significant implications for India’s burgeoning pharmaceutical industry and its global competitiveness.

Karanveer Sharma

A dedicated journalist and legal expert with a passion for uncovering the truth and advocating for justice. With hands-on experience in investigative journalism, legal research, and case analysis, I possess a strong ability to break down complex legal and societal issues into clear, impactful narratives. My work is driven by a commitment to transparency, integrity, and empowering people with accurate, insightful information.